Endothelial cells: from dysfunction mechanism to pharmacological effect in cardiovascular disease H Haybar, S Shahrabi, H Rezaeeyan, R Shirzad, N Saki Cardiovascular Toxicology 19, 13-22, 2019 | 121 | 2019 |
Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis E Khodadi, AA Asnafi, S Shahrabi, M Shahjahani, N Saki Annals of hematology 95, 1765-1776, 2016 | 101 | 2016 |
Wnt/β-catenin signaling in bone marrow niche A Ahmadzadeh, F Norozi, S Shahrabi, M Shahjahani, N Saki Cell and tissue research 363, 321-335, 2016 | 90 | 2016 |
Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells F Norozi, A Ahmadzadeh, S Shahrabi, T Vosoughi, N Saki Tumor Biology 37, 11679-11689, 2016 | 79 | 2016 |
Molecular regulation of bone marrow metastasis in prostate and breast cancer F Rahim, S Hajizamani, E Mortaz, A Ahmadzadeh, M Shahjahani, ... Bone marrow research 2014 (1), 405920, 2014 | 74 | 2014 |
Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis M Shahjahani, J Mohammadiasl, F Noroozi, M Seghatoleslami, ... Cellular Oncology 38, 93-109, 2015 | 65 | 2015 |
Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches AA Asnafi, Z Deris Zayeri, S Shahrabi, K Zibara, T Vosughi Journal of cellular physiology 234 (5), 5798-5806, 2019 | 42 | 2019 |
Significance of oncogenes and tumor suppressor genes in AML prognosis M Kavianpour, A Ahmadzadeh, S Shahrabi, N Saki Tumor Biology 37, 10041-10052, 2016 | 42 | 2016 |
Wnt/β-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target H Haybar, E Khodadi, S Shahrabi Heart Failure Reviews 24, 411-419, 2019 | 39 | 2019 |
Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia H Haybar, S Shahrabi, H Rezaeeyan, H Jodat, N Saki Journal of cellular physiology 234 (9), 14500-14506, 2019 | 38 | 2019 |
Role of stem cell factor in the placental niche E Khodadi, S Shahrabi, M Shahjahani, S Azandeh, N Saki Cell and tissue research 366, 523-531, 2016 | 37 | 2016 |
The role of notch signaling in bone marrow niche S Azizidoost, MS Bavarsad, MS Bavarsad, S Shahrabi, K Jaseb, F Rahim, ... Hematology 20 (2), 93-103, 2015 | 35 | 2015 |
HLAs in autoimmune diseases: dependable diagnostic biomarkers? E Rajaei, MT Jalali, S Shahrabi, AA Asnafi, S Pezeshki Current rheumatology reviews 15 (4), 269-276, 2019 | 33 | 2019 |
Twist as a new prognostic marker in hematological malignancies F Norozi, A Ahmadzadeh, M Shahjahani, S Shahrabi, N Saki Clinical and translational oncology 18, 113-124, 2016 | 32 | 2016 |
New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia S Shahrabi, S Azizidoost, M Shahjahani, F Rahim, A Ahmadzadeh, N Saki Tumor Biology 35, 10627-10633, 2014 | 29 | 2014 |
microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance M Fattahi, S Shahrabi, F Saadatpour, D Rezaee, Z Beyglu, S Delavari, ... International journal of biological macromolecules, 125863, 2023 | 28 | 2023 |
The role of Pax5 in leukemia: diagnosis and prognosis significance M Shahjahani, F Norozi, A Ahmadzadeh, S Shahrabi, F Tavakoli, ... Medical Oncology 32, 1-8, 2015 | 28 | 2015 |
Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer N Ansari, S Shahrabi, A Khosravi, R Shirzad, H Rezaeean Laboratory medicine 50 (3), e36-e41, 2019 | 27 | 2019 |
Thrombocytopenia in leukemia: Pathogenesis and prognosis S Shahrabi, M Maleki Behzad, K Jaseb, N Saki Universidad de Murcia. Departamento de Biología Celular e Histología, 2018 | 26 | 2018 |
Thrombocytopenia in solid tumors: Prognostic significance M Ghanavat, M Ebrahimi, H Rafieemehr, M Maniati, MM Behzad, ... Oncology Reviews 13 (1), 2019 | 24 | 2019 |